217 related articles for article (PubMed ID: 34352292)
1. Effects of the selective dopamine D
Botz-Zapp CA; Foster SL; Pulley DM; Hempel B; Bi GH; Xi ZX; Newman AH; Weinshenker D; Manvich DF
Behav Brain Res; 2021 Oct; 415():113506. PubMed ID: 34352292
[TBL] [Abstract][Full Text] [Related]
2. The highly selective dopamine D
Jordan CJ; Humburg B; Rice M; Bi GH; You ZB; Shaik AB; Cao J; Bonifazi A; Gadiano A; Rais R; Slusher B; Newman AH; Xi ZX
Neuropharmacology; 2019 Nov; 158():107597. PubMed ID: 30974107
[TBL] [Abstract][Full Text] [Related]
3. Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.
Lv Y; Hu RR; Jing M; Zhao TY; Wu N; Song R; Li J; Hu G
Acta Pharmacol Sin; 2019 May; 40(5):583-588. PubMed ID: 30224637
[TBL] [Abstract][Full Text] [Related]
4. Newly Developed Dopamine D
Jordan CJ; Humburg BA; Thorndike EB; Shaik AB; Xi ZX; Baumann MH; Newman AH; Schindler CW
J Pharmacol Exp Ther; 2019 Dec; 371(3):602-614. PubMed ID: 31562201
[TBL] [Abstract][Full Text] [Related]
5. Selective D
Manvich DF; Petko AK; Branco RC; Foster SL; Porter-Stransky KA; Stout KA; Newman AH; Miller GW; Paladini CA; Weinshenker D
Neuropsychopharmacology; 2019 Jul; 44(8):1445-1455. PubMed ID: 30879021
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in rats.
Kumar R; Riddle L; Griffin SA; Grundt P; Newman AH; Luedtke RR
Neuropharmacology; 2009; 56(6-7):944-55. PubMed ID: 19371585
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the dopamine D3 receptor antagonist PG01037 on cocaine and methamphetamine self-administration in rhesus monkeys.
John WS; Newman AH; Nader MA
Neuropharmacology; 2015 May; 92():34-43. PubMed ID: 25576373
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.
Elgueta D; Aymerich MS; Contreras F; Montoya A; Celorrio M; Rojo-Bustamante E; Riquelme E; González H; Vásquez M; Franco R; Pacheco R
Neuropharmacology; 2017 Feb; 113(Pt A):110-123. PubMed ID: 27693549
[TBL] [Abstract][Full Text] [Related]
9. Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.
Kumar V; Bonifazi A; Ellenberger MP; Keck TM; Pommier E; Rais R; Slusher BS; Gardner E; You ZB; Xi ZX; Newman AH
J Med Chem; 2016 Aug; 59(16):7634-50. PubMed ID: 27508895
[TBL] [Abstract][Full Text] [Related]
10. Dopamine D3 receptor-regulated NR2B subunits of N-methyl-d-aspartate receptors in the nucleus accumbens involves in morphine-induced locomotor activity.
Liu XS; Hou Y; Yan TL; Guo YY; Han W; Guan FL; Chen T; Li T
CNS Neurosci Ther; 2014 Sep; 20(9):823-9. PubMed ID: 24797707
[TBL] [Abstract][Full Text] [Related]
11. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H
Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497
[TBL] [Abstract][Full Text] [Related]
12. The novel dopamine D3 receptor antagonists/partial agonists CAB2-015 and BAK4-54 inhibit oxycodone-taking and oxycodone-seeking behavior in rats.
You ZB; Gao JT; Bi GH; He Y; Boateng C; Cao J; Gardner EL; Newman AH; Xi ZX
Neuropharmacology; 2017 Nov; 126():190-199. PubMed ID: 28888944
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration.
Li T; Hou Y; Yan CX; Chen T; Zhao Y; Li SB
Neurosci Lett; 2010 Nov; 485(3):256-60. PubMed ID: 20849922
[TBL] [Abstract][Full Text] [Related]
14. Effects of selective dopamine D3 receptor partial agonist/antagonists on oxycodone self-administration and antinociception in monkeys.
Woodlief K; Allen MI; Cornelissen JC; Banks ML; Newman AH; Nader MA
Neuropsychopharmacology; 2023 Nov; 48(12):1716-1723. PubMed ID: 37118057
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D3 and D2 receptor mechanisms in the abuse-related behavioral effects of cocaine: studies with preferential antagonists in squirrel monkeys.
Achat-Mendes C; Grundt P; Cao J; Platt DM; Newman AH; Spealman RD
J Pharmacol Exp Ther; 2010 Aug; 334(2):556-65. PubMed ID: 20494958
[TBL] [Abstract][Full Text] [Related]
16. C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.
McNamara RK; Levant B; Taylor B; Ahlbrand R; Liu Y; Sullivan JR; Stanford K; Richtand NM
Neuroscience; 2006 Nov; 143(1):141-53. PubMed ID: 16938406
[TBL] [Abstract][Full Text] [Related]
17. Nor-Binaltorphimine Blocks the Adverse Effects of Morphine after Spinal Cord Injury.
Aceves M; Bancroft EA; Aceves AR; Hook MA
J Neurotrauma; 2017 Mar; 34(6):1164-1174. PubMed ID: 27736318
[TBL] [Abstract][Full Text] [Related]
18. Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice.
Marinho EA; Oliveira-Lima AJ; Santos R; Hollais AW; Baldaia MA; Wuo-Silva R; Yokoyama TS; Takatsu-Coleman AL; Patti CL; Longo BM; Berro LF; Frussa-Filho R
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Apr; 58():22-31. PubMed ID: 25496830
[TBL] [Abstract][Full Text] [Related]
19. Current Perspectives on Selective Dopamine D
Newman AH; Xi ZX; Heidbreder C
Curr Top Behav Neurosci; 2023; 60():157-201. PubMed ID: 35543868
[TBL] [Abstract][Full Text] [Related]
20. G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.
Nakamura A; Fujita M; Ono H; Hongo Y; Kanbara T; Ogawa K; Morioka Y; Nishiyori A; Shibasaki M; Mori T; Suzuki T; Sakaguchi G; Kato A; Hasegawa M
Br J Pharmacol; 2014 Jan; 171(1):253-64. PubMed ID: 24117458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
